982 resultados para Mechel, C. v., 1737-1818.
Resumo:
2005
Resumo:
2011
Resumo:
No primeiro ano de realização dos ensaios cooperativos para o controle da mancha-alvo observou-se que há necessidade de ajustes na metodologia, como, por exemplo, não iniciar as aplicações no estádio vegetativo nos ensaios cooperativos. Como as aplicações se iniciaram muito cedo nos ensaios, sendo limitadas a três aplicações, a última aplicação foi realizada entre os estádios R3 e R5, comprometendo a proteção das plantas no final do ciclo da cultura e a porcentagem de controle final dos tratamentos. No entanto, pôde-se observar que há diferença entre os produtos, objetivo principal dos ensaios. Os fungicidas do grupo dos benzimidazóis, amplamente utilizados no campo para controle da mancha-alvo, apresentaram eficiência inferior aos outros produtos. Os produtos com maior eficiência nos ensaios não possuem registro no MAPA até o momento. Outra variável que deve ser analisada com maior rigor é o potencial de dano da mancha-alvo. Para os ensaios cooperativos foram utilizadas cultivares relatadas como suscetÃveis no campo e, mesmo assim, a média de redução de produtividade para a testemunha sem controle foi baixa, de 10,3%. Conhecer a reação das cultivares pode auxiliar na definição da necessidade de controle quÃmico especÃfico para essa doença.
Resumo:
O objetivo deste trabalho foi identificar as principais ocorrências de solos na região do Oeste baiano, para subsidiar com informações e propor alternativos de manejo.
Resumo:
2013
Resumo:
2015
Resumo:
2015
Resumo:
2015
Resumo:
2015
Resumo:
2015
Resumo:
Dissertação de Mestrado apresentada à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Psicologia ClÃnica e da Saúde.
Resumo:
This text presents an analysis of aggregated membership’s dynamics for Spanish trade unions, using ECVT data, as well as union memberships’ trajectories, or members’ decisions about joining the organization, permanency and responsibilities, and subsequent attrition. For the analysis of trajectories we make use of information of the records of actual memberships and the record of quitting of CCOO, and of a survey-questionnaire to a sample of leavers of the same union. This study allows us to confirm a linkage between the decision and motivations to become union member, to participate in union activities, the time of permanency, and the motives to quit the organization. We also identify five types of union members’ trajectories, indicating that, far from views that assert a monolithic structure, unions are complex organizations.
Resumo:
Objectives: Cilostazol improves walking distance in peripheral arterial disease (PAD) patients. The study objectives were to assess the effects of cilostazol on walking distance, followed by the additional assessment of cilostazol on exercise-induced ischaemiaereperfusion injury in such patients.
Methods: PAD patients were prospectively recruited to a double-blinded, placebo-controlled trial. Patients were randomised to receive either cilostazol 100 mg or placebo twice a day. The primary end-point was an improvement in walking distance. Secondary end-points included the assessment of oxygen-derived free-radical generation, antioxidant consumption and other markers of the in?ammatory cascade. Initial and absolute claudication distances (ICDs and ACDs, respectively) were measured on a treadmill. In?ammatory response was assessed before and 30 min post-exercise by measuring lipid hydroperoxide, ascorbate, atocopherol, b-carotene, P-selectin, intracellular and vascular cell-adhesion molecules (I-CAM and V-CAM), thromboxane B2 (TXB2), interleukin-6, interleukin-10, high-sensitive C-reactive protein (hsCRP), albuminecreatinine ratio (ACR) and urinary levels of p75TNF receptor. All tests were performed at baseline and 6 and 24 weeks.
Results: One hundred and six PAD patients (of whom 73 were males) were recruited and successfully randomised from December 2004 to January 2006. Patients who received cilostazol demonstrated a more signi?cant improvement in the mean percentage change from baseline in ACD (77.2% vs. 26.6% at 6 weeks, pZ0.026 and 161.7% vs. 79.0% at 24 weeks, pZ0.048) as compared to the placebo. Cilostazol reduced lipid hydroperoxide levels compared to a placebo-related increase before and after exercise (6 weeks: pre-exercise: 11.8% vs.